Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus
- 20 May 2009
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 385 (3) , 390-394
- https://doi.org/10.1016/j.bbrc.2009.05.066
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- How does each substituent functional group of oseltamivir lose its activity against virulent H5N1 influenza mutants?Biophysical Chemistry, 2009
- Why Amantadine Loses Its Function in Influenza M2 Mutants: MD SimulationsJournal of Chemical Information and Modeling, 2009
- Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutationAmino Acids, 2008
- How amantadine and rimantadine inhibit proton transport in the M2 protein channelJournal of Molecular Graphics and Modelling, 2008
- Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1Proteins-Structure Function and Bioinformatics, 2008
- Backbone Structure of the Amantadine-Blocked Trans-Membrane Domain M2 Proton Channel from Influenza A VirusBiophysical Journal, 2007
- On the Lower Susceptibility of Oseltamivir to Influenza Neuraminidase Subtype N1 than Those in N2 and N9Biophysical Journal, 2007
- Antiviral agents active against influenza A virusesNature Reviews Drug Discovery, 2006
- The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug designNature, 2006
- Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy functionJournal of Computational Chemistry, 1998